Atea Pharmaceuticals, Inc. (AVIR)

4.65 +0.06 (+1.31%) USD  |  NASDAQ  |  Feb 24, 16:00
More

Atea Pharmaceuticals Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for AVIR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
Oramed Pharmaceuticals, Inc. Upgrade
Aclaris Therapeutics, Inc. Upgrade
PMV Pharmaceuticals, Inc. Upgrade
Instil Bio, Inc. Upgrade
Coya Therapeutics, Inc. Upgrade